Evidence map›Paper›PMID 36560699›Full record

ArticleViruses2022

Biology and Ultrastructural Characterization of Grapevine Badnavirus 1 and Grapevine Virus G.

Martin Jagunić, Angelo De Stradis, Darko Preiner, Pierfederico La Notte, Maher Al Rwahnih, Rodrigo P P Almeida, Darko Vončina

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Emerging and Re-Emerging Diseases Caused by Badnaviruses.Pathogens (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Martin JagunićDepartment of Plant Pathology, University of Zagreb Faculty of Agriculture, 10000 Zagreb, Croatia.ORCID 0000-0003-0959-6296
Angelo De StradisNational Research Council of Italy, Institute for Sustainable Plant Protection, Via Amendola 122/D, 70126 Bari, Italy.ORCID 0000-0003-1624-2365
Darko PreinerDepartment of Viticulture and Enology, University of Zagreb Faculty of Agriculture, 10000 Zagreb, Croatia.ORCID 0000-0003-4598-2207
Pierfederico La NotteNational Research Council of Italy, Institute for Sustainable Plant Protection, Via Amendola 122/D, 70126 Bari, Italy.
Maher Al RwahnihFoundation Plant Services, University of California-Davis, Davis, CA 95616, USA.ORCID 0000-0003-1589-9234
Rodrigo P P AlmeidaDepartment of Environmental Science, Policy and Management, Rausser College of Natural Resources, University of California, 130 Mulford Hall, Berkeley, CA 94720, USA.ORCID 0000-0003-2888-9617
Darko VončinaDepartment of Plant Pathology, University of Zagreb Faculty of Agriculture, 10000 Zagreb, Croatia.ORCID 0000-0001-6093-5471
University of Zagreb · HRInstitute for Sustainable Plant Protection · ITUniversity of California, Berkeley · USUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological characteristics of grapevine viruses, such as their transmission and host range, are important for the adoption of successful prophylaxis strategies. The aim of this study was to investigate the traits of two newly described grapevine viruses widely distributed in Croatia, grapevine badnavirus 1 (GBV-1) and grapevine virus G (GVG). The vine mealybug (

Indexed as

BadnavirusFlexiviridaeVitisBiologyPlant Diseasescytopathologygrapevine badnavirus 1grapevine virus Ghost rangereal-time PCRtransmission modes

Identifiers

PMID36560699
PMCPMC9787950
OpenAlexW4311049362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.